Skip to main content
. Author manuscript; available in PMC: 2014 Jul 11.
Published in final edited form as: Am J Manag Care. 2013 Mar 1;19(3):e85–e92.

Table 2.

Cross-Method Agreement of Self-Reported Adherence With Electronic Monitoring Over Time (n = 180)

Oral Hypoglycemic Agent Electronic Monitoring Adherence
Self-Reported Adherence
Adherence Agreement
Kappa Coefficient
n (%) n (%) Kappa P
 Baseline 77 (42.8%) 146 (81.1%) 0.133 .012

 6 weeks 112 (62.2%) 137 (76.1%) 0.147 .038

 12 weeks 118 (65.6%) 131 (72.8%) 0.210 .004

Antidepressants

 Baseline 69 (38.3%) 133 (73.9%) 0.180 .002

 6 weeks 104 (57.8%) 136 (75.6%) 0.179 .009

 12 weeks 105 (58.3%) 127 (70.6%) 0.380 <.001

Adherence was operationalized as ≥80% adherence. n = number of participants who were adherent by method of adherence.

HHS Vulnerability Disclosure